January 06, 2014
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
FDA approves lacrimal duct balloon catheter
The U.S. Food and Drug Administration has approved the OphtaCath lacrimal duct balloon catheter from FCI Ophthalmics, according to a press release.
The OphtaCath achieves dilation of the lacrimal duct and treats the symptoms of epiphora, according to the release. It is a less invasive alternative to incisional procedures and eliminates the placement of tubes.
It is packaged in sterile 2-mm or 3-mm kits with one or two balloon catheters and a disposable inflation device.